/
BIOQ
$32.50+$0.00 (+0.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$32.50 – $43.55
0% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-71.50
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $35.9M | $39.5M | $46.4M | $57.7M | $66.2M | $62.7M | $58.6M | $48.9M |
| Cost of revenue | $27.2M | $32.1M | $36.7M | $43.7M | $53.1M | $50.1M | $51.2M | $50.8M |
| Gross profit | $8.7M | $7.4M | $9.7M | $14.0M | $13.0M | $12.6M | $7.4M | −$1.9M |
| Gross margin | 24.3% | 18.8% | 20.9% | 24.2% | 19.7% | 20.1% | 12.7% | -3.9% |
| R&D | $331.5K | $331.5K | $1.1M | $828.8K | $1.1M | $806.0K | $0 | $0 |
| Operating income | $5.3M | $3.6M | $5.3M | $8.6M | $6.5M | $1.1M | −$19.6K | −$1.9M |
| EBITDA | $6.1M | $4.6M | $9.8M | $13.1M | $14.8M | $7.0M | $3.0M | $509.6K |
| Net income | $3.7M | $2.8M | $4.2M | $6.3M | $5.3M | $835.5K | $483.5K | −$1.0M |
| Net margin | 10.2% | 7.2% | 9.1% | 11.0% | 8.0% | 1.3% | 0.8% | -2.1% |
| EPS (diluted) | 4.10 | 3.17 | 4.73 | 7.08 | 5.88 | 0.93 | 0.54 | -1.17 |
Annual figures · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$148.25
Price
$32.50
Implied upside
+356%
Peer comparison
BIOQUAL INC
BIOQUAL INC
Held by traders on TradeandTell
No one on the platform currently holds BIOQ.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in BIOQ as of their last filing.
Insider activity (SEC Form 4)
Dividend history
TTM yield · 3.08% ($1.00/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2024-10-07 | $0.5000 | 2024-10-28 |
| 2023-10-05 | $0.5000 | 2023-10-27 |
Recent trades on TradeandTell
No one on the platform has traded BIOQ yet.